Wealth Enhancement Advisory Services
ITCI

Wealth Enhancement Advisory Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,576
Closed -$1.66M – 3516
2025
Q1 		$1.66M Buy
12,576
+566
+5% +$70.5K ﹤0.01% 1345
2024
Q4 		$1M Buy
12,010
+3,200
+36% +$263K ﹤0.01% 1545
2024
Q3 		$645K Buy
8,810
+5,725
+186% +$430K ﹤0.01% 1647
2024
Q2 		$211K Buy
+3,085
New +$214K ﹤0.01% 2258

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wealth Enhancement Advisory Services's ITCI Position: Q2 2025 in Review

Wealth Enhancement Advisory Services sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 12,576 shares — an estimated $1.66M sold.

Wealth Enhancement Advisory Services first reported a position in ITCI in Q2 2024 and held it in 4 quarters. The position peaked at $1.66M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Wealth Enhancement Advisory Services reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 12,576 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.66M.
  • Wealth Enhancement Advisory Services first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 4 quarters.
  • Wealth Enhancement Advisory Services's Intra-Cellular Therapies Inc. position peaked at $1.66M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.